NPHLA Daily
NPHLA Daily
Monday, October 26, 2026 · 4-minute read
Good morning. Here is what changed across metabolic medicine, pharmacy regulation, aesthetics and healthcare technology since yesterday — every item linked to its source.
Top development today
What changed today in AI & Technology: 3 new studies
NPHLA tracked 3 new official records on this desk today: 3 new studies. First: New research in Nuclear medicine communications: “From chatbot to clinical copilot: the role of generative artificial intelligence in nuclear medicine reporting and data extraction”.
Metabolic signal
What changed today in Metabolic: 1 new study
NPHLA tracked 1 new official record on this desk today: 1 new study. First: New research in Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery: “[Efficacy and safety of GLP-1 receptor agonists combined with bariatric surgery for obesity: a…
AI & Technology signal
From chatbot to clinical copilot: the role of generative artificial intelligence in nuclear medicine reporting and data extraction
From Nuclear medicine communications.
One thing worth watching
Comments close: Agency Information Collection Activities; Proposed Collection; Comment Request; Registration of Human Drug Compounding Outsourcing Facilities Under the Federal Food, Drug, and…
October 29, 2026 — verified from the Federal Register comments_close_on.
5 things to know
- What changed today in AI & Technology: 3 new studies
- What changed today in Metabolic: 1 new study
- From chatbot to clinical copilot: the role of generative artificial intelligence in nuclear medicine reporting and data extraction (Nuclear medicine communications)
- Beyond documentation burden: clinician-reported workflow and cognitive changes associated with ambient documentation technology (JAMIA open)
- [Efficacy and safety of GLP-1 receptor agonists combined with bariatric surgery for obesity: a timing-stratified systematic review] (Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery)
Compiled by NPHLA Intelligence from published briefings and official records. Professional information only — not medical or legal advice. Our standards.